ALDER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 014339AA3. A total of 1 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $59,236,000 | +0.3% | 53,517,000 | -15.7% | 6.61% | +13.6% |
| Q2 2019 | $59,031,000 | +17.8% | 63,517,000 | +20.9% | 5.81% | +28.3% |
| Q1 2019 | $50,131,000 | +109.5% | 52,517,000 | +75.1% | 4.53% | +20.4% |
| Q4 2018 | $23,930,000 | +11.8% | 30,000,000 | +50.0% | 3.76% | +87.2% |
| Q3 2018 | $21,398,000 | +3.0% | 20,000,000 | 0.0% | 2.01% | +7.5% |
| Q2 2018 | $20,776,000 | – | 20,000,000 | – | 1.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 52,517,000 | $50,131,000 | 4.53% |
| Mohican Financial Management, LLC | 1,250,000 | $1,196,000 | 3.90% |
| Redmile Group, LLC | 25,000,000 | $23,865,000 | 0.70% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,195,000 | $30,920,000 | 0.42% |
| PFM Health Sciences, LP | 17,213,000 | $16,517,000 | 0.36% |
| SSI INVESTMENT MANAGEMENT LLC | 2,750,000 | $2,626,000 | 0.22% |
| Rock Springs Capital Management LP | 5,000,000 | $4,798,000 | 0.18% |
| Partner Investment Management, L.P. | 137,000 | $131,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,000,000 | $3,830,000 | 0.12% |
| DAFNA Capital Management LLC | 250,000 | $240,000 | 0.10% |